FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia.
Clin Cancer Res
; 24(14): 3242-3246, 2018 07 15.
Article
in En
| MEDLINE
| ID: mdl-29476018
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Drug Approval
/
Sialic Acid Binding Ig-like Lectin 3
/
Antineoplastic Agents, Immunological
/
Gemtuzumab
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2018
Type:
Article